Next Article in Journal
Multilevel Disparities of Sex-Differentiated Human Papilloma Virus-Positive Oropharyngeal Cancers in the United States
Previous Article in Journal
Early Diagnosis of Huntington Disease: Insights from Magnetic Resonance Spectroscopy—A Systematic Review
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
JCM
Volume 13
Issue 21
10.3390/jcm13216388
jcm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Retraction of J. Clin. Med. 2024, 13(11), 3262.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Retraction

RETRACTED: Jeong et al. A Phase III Head-to-Head Study to Compare the Efficacy and Safety of Fexuprazan and Esomeprazole in Treating Patients with Erosive Esophagitis. J. Clin. Med. 2024, 13, 3262

by
Yuchul Jeong
1,
Beom Jun Lee
2 and
Se-Hyeon Han
3,*
1
Department of Internal Medicine, Chungna Good Hospital, Incheon 22738, Republic of Korea
2
St. Mary’s Best ENT Clinic, Seoul 08849, Republic of Korea
3
Department of Companion Animal Industry, College of Health Science, Honam University, Gwangju 62399, Republic of Korea
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2024, 13(21), 6388; https://doi.org/10.3390/jcm13216388
Submission received: 23 October 2024 / Accepted: 23 October 2024 / Published: 25 October 2024
(This article belongs to the Section Gastroenterology & Hepatopancreatobiliary Medicine)
Versions Notes
The Journal of Clinical Medicine retracts the article entitled “A Phase III Head-to-Head Study to Compare the Efficacy and Safety of Fexuprazan and Esomeprazole in Treating Patients with Erosive Esophagitis” [1].
Following publication, concerns were brought to the attention of the Editorial Office regarding an overlap between this publication [1] and a previous publication [2], produced by a different authorship group.
Adhering to our complaint’s procedure, an investigation was conducted by the Editorial Office and the Editorial Board that confirmed a significant similarity between the data presented in the two publications [1,2]. As a result, the Editorial Board consider this publication [1] to be redundant, and therefore have decided to retract it as per MDPI’s retraction policy (https://www.mdpi.com/ethics#_bookmark30, accessed on 22 October 2024).
This retraction was approved by the Editor-in-Chief of the Journal of Clinical Medicine.
The authors agreed to this retraction.

References

  1. Jeong, Y.; Lee, B.J.; Han, S.-H. RETRACTED: A Phase III Head-to-Head Study to Compare the Efficacy and Safety of Fexuprazan and Esomeprazole in Treating Patients with Erosive Esophagitis. J. Clin. Med. 2024, 13, 3262. [Google Scholar] [CrossRef] [PubMed]
  2. Lee, K.N.; Lee, O.Y.; Chun, H.J.; Kim, J.I.; Kim, S.K.; Lee, S.W.; Park, K.S.; Lee, K.L.; Choi, S.C.; Jang, J.Y.; et al. Randomized controlled trial to evaluate the efficacy and safety of fexuprazan compared with esomeprazole in erosive esophagitis. World J. Gastroenterol. 2022, 28, 6294–6309. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Jeong, Y.; Lee, B.J.; Han, S.-H. RETRACTED: Jeong et al. A Phase III Head-to-Head Study to Compare the Efficacy and Safety of Fexuprazan and Esomeprazole in Treating Patients with Erosive Esophagitis. J. Clin. Med. 2024, 13, 3262. J. Clin. Med. 2024, 13, 6388. https://doi.org/10.3390/jcm13216388

AMA Style

Jeong Y, Lee BJ, Han S-H. RETRACTED: Jeong et al. A Phase III Head-to-Head Study to Compare the Efficacy and Safety of Fexuprazan and Esomeprazole in Treating Patients with Erosive Esophagitis. J. Clin. Med. 2024, 13, 3262. Journal of Clinical Medicine. 2024; 13(21):6388. https://doi.org/10.3390/jcm13216388

Chicago/Turabian Style

Jeong, Yuchul, Beom Jun Lee, and Se-Hyeon Han. 2024. "RETRACTED: Jeong et al. A Phase III Head-to-Head Study to Compare the Efficacy and Safety of Fexuprazan and Esomeprazole in Treating Patients with Erosive Esophagitis. J. Clin. Med. 2024, 13, 3262" Journal of Clinical Medicine 13, no. 21: 6388. https://doi.org/10.3390/jcm13216388

APA Style

Jeong, Y., Lee, B. J., & Han, S.-H. (2024). RETRACTED: Jeong et al. A Phase III Head-to-Head Study to Compare the Efficacy and Safety of Fexuprazan and Esomeprazole in Treating Patients with Erosive Esophagitis. J. Clin. Med. 2024, 13, 3262. Journal of Clinical Medicine, 13(21), 6388. https://doi.org/10.3390/jcm13216388

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop